Fifteen-year-old Will Roberts recorded a video on his mother’s phone while facing stage 4 osteosarcoma, an aggressive form of bone cancer. He was not seeking attention, but help and awareness as his condition worsened and standard treatments were no longer effective.

In the video, Will spoke openly about his illness and the barriers to accessing experimental treatments. He mentioned DeltaRex-G, an investigational therapy, and urged viewers to help bring attention to options that might extend his life.

The post, shared on social media, quickly went viral and reached millions of viewers. It spread beyond social platforms into broader public discussion, drawing attention from medical advocates, policymakers, and public figures.

The attention brought both emotional strain and practical support for Will and his family. While being in the public eye was difficult, the response also helped generate financial assistance and wider awareness of pediatric cancer challenges.

Crowdfunding efforts grew rapidly, helping the family manage costs related to travel, care, and specialized treatment. Supporters from different communities contributed to easing the financial burden of seeking advanced medical care.

Eventually, Will was connected with a specialized treatment center in California known for treating complex sarcoma cases. This gave him access to additional options not previously available in his home state.

His situation highlights broader issues in healthcare, particularly the difficulty of accessing experimental or advanced treatments for critically ill patients. It has sparked discussion about how medical systems evaluate and approve emerging therapies.

Ultimately, Will’s story has become a symbol of resilience and advocacy, showing how a single voice—shared widely—can raise awareness about serious illness and inspire conversations about medical access, hope, and the limits of current treatment options.